Stop Patent Hops: Detecting “Evergreening” Patterns Through Sequential FDA Orange Book Listings
In the relentless race to extend pharmaceutical exclusivity, "evergreening" has become a strategic game played by some of the world’s largest drug companies. But what if there was a way to detect these tactics early—before they drain innovati…
